The Chemours Company (CC) To Go Ex-Dividend on February 27th

The Chemours Company (NYSE:CC) declared a quarterly dividend on Tuesday, February 17th. Stockholders of record on Friday, February 27th will be paid a dividend of 0.0875 per share by the specialty chemicals company on Friday, March 13th. This represents a c) annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Friday, February 27th.

Chemours has decreased its dividend payment by an average of 0.1%annually over the last three years. Chemours has a dividend payout ratio of 14.5% meaning its dividend is sufficiently covered by earnings. Analysts expect Chemours to earn $2.71 per share next year, which means the company should continue to be able to cover its $0.35 annual dividend with an expected future payout ratio of 12.9%.

Chemours Price Performance

Shares of NYSE:CC traded down $0.51 during midday trading on Wednesday, hitting $17.90. The company had a trading volume of 206,203 shares, compared to its average volume of 3,493,324. Chemours has a twelve month low of $9.13 and a twelve month high of $21.85. The stock has a market cap of $2.68 billion, a price-to-earnings ratio of -7.22 and a beta of 1.63. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.78 and a quick ratio of 0.85. The business’s 50-day simple moving average is $15.50 and its 200-day simple moving average is $14.55.

Chemours (NYSE:CC) last issued its earnings results on Thursday, February 19th. The specialty chemicals company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.04. Chemours had a positive return on equity of 41.75% and a negative net margin of 6.41%.The company had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same period in the prior year, the business earned $0.09 EPS. The firm’s quarterly revenue was down 2.2% on a year-over-year basis. On average, research analysts predict that Chemours will post 2.03 earnings per share for the current year.

Hedge Funds Weigh In On Chemours

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Atlas Capital Advisors Inc. purchased a new position in Chemours in the fourth quarter valued at $26,000. MTM Investment Management LLC acquired a new stake in Chemours in the 2nd quarter valued at about $27,000. Aster Capital Management DIFC Ltd acquired a new position in shares of Chemours during the fourth quarter worth about $28,000. Covestor Ltd increased its stake in shares of Chemours by 204.7% during the fourth quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock worth $31,000 after buying an additional 1,748 shares during the period. Finally, Eurizon Capital SGR S.p.A. acquired a new stake in Chemours in the fourth quarter valued at approximately $31,000. Hedge funds and other institutional investors own 76.26% of the company’s stock.

About Chemours

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.